Skip to main content
. Author manuscript; available in PMC: 2012 Oct 16.
Published in final edited form as: Asian J Androl. 2012 Feb 20;14(3):405–408. doi: 10.1038/aja.2011.149

Figure 2.

Figure 2

Serum Cyr61 levels measured by sandwich ELISA. (a) Cyr61 concentrations in serum samples obtained from OC-PCa (n=58) and NOC-PCa (n=57) patients, demonstrating significant difference (*P=0.031). (b) Cyr61 concentrations in serum samples obtained from PCa patients without PSA recurrence (Non-Rec, n=10) and those with PSA recurrence (Rec, n=10), demonstrating no significant difference (P=0.082). This figure is reproduced from D’Antonio et al.19 Cyr61, cysteine-rich angiogenic inducer 61; NOC, non-organ-confined; OC, organ-confined; PCa, prostate cancer.